32
Views
0
CrossRef citations to date
0
Altmetric
Correction notice

The emerging field of senotherapeutic drugs

This article refers to:
The Emerging Field of Senotherapeutic Drugs

Article title: The Emerging Field of Senotherapeutic Drugs

Authors: Vassilios Myrianthopoulos

Journal: Future Medicinal Chemistry

Bibliometrics: Volume 10, Number 20, pages 2369–2372

DOI: https://doi.org/10.4155/fmc-2018-0234

The Editorial titled ‘The emerging field of senotherapeutic drugs’ was published with an error.

The phrase:

‘Regarding the mechanistic aspects of metformin senotherapeutic effects, it was shown that SASP suppression was not directly related with AMPK kinase inhibition, a strong candidate mechanism for the antidiabetic action, but it was associated with inhibition of IKK, a different kinase upstream of NF-κB [19].’

has been corrected with:

‘Regarding the mechanistic aspects of metformin senotherapeutic effects, it was shown that SASP suppression was not directly related with AMPK kinase activation, a strong candidate mechanism for the antidiabetic action, but it was associated with inhibition of IKK, a different kinase upstream of NF-κB [19].’

This article was originally published with errors, which have now been corrected in the online version. Please see Correction (https://doi.org/10.4155/fmc-2018-0234)

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.